OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

11118	Companies
244805	Keywords
172884	Articles
131993	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 12/01/2025 at 08:00, 10 months 2 days ago

Oxurion secures a binding EUR 30 million financing facility dedicated to investments in digital and crypto assets
Oxurion NV secures €30 million financing via convertible bonds from Atlas Capital Markets to invest in digital assets like Bitcoin and Ethereum. The strategy aligns with the company's long-term investment policy

Convertible Bonds Bitcoin Digital Assets Finance Oxurion NV
BRIEF

published on 11/25/2025 at 18:05, 10 months 8 days ago

Oxurion receives a transparency notification from Atlas Special Opportunities II LLC

Actions Transparency Health Oxurion Atlas Special Opportunities II LLC
PRESS RELEASE

published on 11/25/2025 at 18:00, 10 months 8 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a change in share ownership. The company specializes in acquiring stakes in European pharmaceutical subcontractors

Transparency Notification Share Ownership Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors
BRIEF

published on 11/20/2025 at 18:05, 10 months 13 days ago

Oxurion receives a transparency notification from Atlas Special Opportunities II LLC

Digital Assets Transparency Notification Belgium Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 11/20/2025 at 18:00, 10 months 13 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC indicating a decrease in shareholding percentage due to sale of voting securities

Transparency Notification Oxurion NV Voting Securities Atlas Special Opportunities II, LLC Shareholding Percentage
BRIEF

published on 11/03/2025 at 18:05, 11 months ago

Oxurion Concludes Preclinical Discussions, Focuses on Strategic Clinical Integration

Strategic Acquisition Oxurion Clinical Integration Pharmaceutical Subcontractors Preclinical Termination
PRESS RELEASE

published on 11/03/2025 at 18:00, 11 months ago

Oxurion ends discussions regarding previously announced preclinical transaction and continues integration of a strategic clinical partner
Oxurion NV terminates acquisition discussions but moves forward with clinical integration and consolidation strategy. Upholding financial discipline and commitment to high-value services

High-value Services Oxurion NV Consolidation Strategy Clinical Integration Acquisition Termination
BRIEF

published on 10/23/2025 at 18:05, 11 months 11 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion Belgian Regulations
PRESS RELEASE

published on 10/23/2025 at 18:00, 11 months 11 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing. The company specializes in acquiring stakes in European pharmaceutical subcontractors

Transparency Notification Shareholding Threshold Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors
BRIEF

published on 10/17/2025 at 18:05, 11 months 17 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion

Accesswire

Published on 10/03/2026 at 02:35, 1 day 2 hours ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 1 day 11 hours ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 1 day 14 hours ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 15 hours ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 15 hours ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/03/2026 at 15:45, 13 hours 1 minute ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 4 hours ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 8 hours ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 8 hours ago

innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day 10 hours ago

EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)

Les Echos

Published on 10/02/2026 at 17:45, 1 day 11 hours ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:30, 1 day 11 hours ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/01/2026 at 19:00, 2 days 9 hours ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 2 days 10 hours ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days 10 hours ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE